Scientific Program

Scientific Program

  14:00 – 14:10

WELCOME ADDRESS

Dirk Busch, Technical University of Munich, Germany
Adi Barzel, Tel-Aviv University, Israel

  14:10 – 14:45

KEYNOTE LECTURE 

Michel Sadelain, Memorial Sloan Kettering Cancer Center, USA

  14:45 – 15:45

SESSION 1: UPDATE ON THE APPROVED THERAPIES 

  15:45 – 16:30

COFFEE BREAK, EXHIBITION AND POSTER PRESENTATIONS 

  16:30 – 18:05

SESSION 2 : CURRENTLY ONGOING CLINICAL TRIALS 

Claire Roddie, University College London, UK

Michael Hudecek, University Hospital Würzburg, Germany

Parsad Adusumilli, Memorial Sloan Kettering Cancer Center, USA

TBA

Panel Discussion

  18:05 -18:15

SHORT BREAK

  18:15 – 19:30

PRESENTATIONS OF THE TOP POSTERS

  20:00 – 21:30

SOCIAL EVENT

  08:30 – 9:50

SESSION 3: SUPERPOWERED LYMPHOCYTES

George Coukos, Lausanne University Hospital, Switzerland

Sebastian Kobold, Ludwig Maximilian University of Munich, Germany

TBA

Panel Discussion

  09:50 – 10:35

COFFEE BREAK, EXHIBITION, INDUSTRY & POSTER PRESENTATIONS

  10:35 – 12:00

SESSION 4: NON VIRAL CAR/TCR ENGINEERING

Zoltan Ivic, Paul-Ehrlich-Institut, Germany

Chiara Magnani, University of Zurich, Switzerland

TBA

Panel Discussion

  12:00 – 12:10

SHORT BREAK

  12:10 – 13:10

INDUSTRY SUPPORTED SESSION

  13:10 – 14:45

LUNCH BREAK, EXHIBITION, INDUSTRY & POSTER PRESENTATIONS

  14:45 – 16:10

SESSION 5: UNIVERSAL DONOR CELLS & ADVANCED TCR ENGINEERING

Keynote lecture by Malcolm Brenner, Baylor College of Medicine, USA

Dirk Busch, Technical University of Munich, Germany

Chiara Bonini, Vita-Salute San Raffaele University, Italy

TBA

Panel Discussion

  16:10 – 17:00

COFFEE BREAK, EXHIBITION & POSTER PRESENTATIONS 

  17:00 – 18:20

SESSION 6: BEYOND ALPHA-BETA T CELLS

Jurgen Kuball, University Medical Center Utrecht, Netherlands

Giulia Casorati, San Raffaele Hospital, Italy

TBA

Panel Discussion

  18:20 – 18:30

SHORT BREAK

  18:30 – 19:45

SESSION 7: NOVEL CLINICAL APPROACHES AND COMBINATION THERAPIES

Stanley Riddell, Fred Hutchinson Cancer Research Center, USA

Luigi Naldini, San Raffaele Telethon Institute for Gene Therapy, Italy

TBA

Panel Discussion

  08:30 – 9:50

SESSION 8: TARGETING NON-MALIGNANT DISEASES

Hans Stauss, University College London, UK

George Schett, University of Erlangen–Nuremberg, Germany

TBA

Panel Discussion

  09:50 – 10:50

SESSION 9: SELECTED ABSTRACTS FOR ORAL PRESENTATION

  10:50 – 11:40

COFFEE BREAK, EXHIBITION, POSTER PRESENTATIONS

  11:40 – 12:55

SESSION 10: IN VIVO T CELL ENGINEERING

Adi Barzel, Tel Aviv University, Israel

Christian Buchholz, Paul-Ehrlich-Institut, Germany

TBA

Panel Discussion

  12:55 – 13:15

SESSION 11: BEST POSTER ANNOUNCEMENT & CONFERENCE CLOSURE

Moderators: Adi Barzel, Tel-Aviv University, Israel
Dirk Busch, Technical University of Munich, Germany

*The program could be subject to changes.